Philip G. Vanek, Ph.D.

GM Cell and Gene Therapy Strategy, GE Healthcare

Phil is General Manager of GE Healthcare’s Cell and Gene Therapy business strategy, a business formed to address the unique challenges of cell and gene therapy manufacturing and distribution. Earlier, Phil was Head of Business Development for Cell Therapy, and later Head of Innovation for Lonza’s life science business.

Phil received his Ph.D. in Biochemistry and Molecular Biology from Georgetown University Medical Center and subsequently held an IRTA fellowship at the National Cancer Institute and the Hollings Cancer Center in Charleston, SC.

Phil is an active board member of the Alliance for Regenerative Medicine, the ARM Foundation, and CCRM.